APA citiranje

Riazi-Esfahani, M., Ahmadieh, H., Faghihi, H., Piri, N., Taei, R., Karkhaneh, R., . . . Sanagou, M. (2008). Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration. Ophthalmic Research Center.

Citação norma Chicago

Riazi-Esfahani, Mohammad, et al. Intravitreal Bevacizumab Versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration. Ophthalmic Research Center, 2008.

MLA citiranje

Riazi-Esfahani, Mohammad, et al. Intravitreal Bevacizumab Versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration. Ophthalmic Research Center, 2008.